Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,334 | 460 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $895.28 | 41 | $0 (2024) |
| Novo Nordisk Inc | $883.34 | 43 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $866.96 | 41 | $0 (2024) |
| ABBVIE INC. | $590.80 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $550.93 | 33 | $0 (2024) |
| PFIZER INC. | $547.07 | 37 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $510.94 | 30 | $0 (2023) |
| Allergan, Inc. | $400.82 | 24 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $399.42 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $386.02 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $395.13 | 19 | Abbott Laboratories ($68.03) |
| 2023 | $829.69 | 38 | ABBVIE INC. ($287.55) |
| 2022 | $667.61 | 30 | Amgen Inc. ($236.02) |
| 2021 | $688.27 | 32 | AbbVie Inc. ($202.31) |
| 2020 | $897.67 | 51 | Kowa Pharmaceuticals America, Inc. ($120.57) |
| 2019 | $1,807 | 111 | Boehringer Ingelheim Pharmaceuticals, Inc. ($276.94) |
| 2018 | $2,015 | 113 | Novo Nordisk Inc ($365.36) |
| 2017 | $1,033 | 66 | Boehringer Ingelheim Pharmaceuticals, Inc. ($187.69) |
All Payment Transactions
460 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Diabetes Care | ||||||
| 06/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.21 | General |
| 06/04/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Diabetes Care | ||||||
| 04/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Diabetes Care | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Inflammation | ||||||
| 03/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: VACCINE | ||||||
| 02/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes Care | ||||||
| 02/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.85 | General |
| 02/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Inflammation | ||||||
| 02/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Biological | ||||||
| 01/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Inflammation | ||||||
| 01/22/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Inflammation | ||||||
| 11/26/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV, OFEV | Food and Beverage | In-kind items and services | $27.13 | General |
| 11/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 712 | 1,029 | $364,886 | $95,426 |
| 2022 | 21 | 1,013 | 1,355 | $421,874 | $105,037 |
| 2021 | 24 | 1,224 | 1,842 | $493,943 | $123,347 |
| 2020 | 19 | 1,002 | 1,341 | $344,902 | $88,981 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 256 | 530 | $234,782 | $55,112 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 180 | 180 | $80,100 | $27,445 | 34.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 60 | 88 | $27,544 | $6,989 | 25.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 40 | 40 | $8,000 | $3,032 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 43 | $3,655 | $1,547 | 42.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 48 | $960.00 | $394.80 | 41.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 36 | 40 | $6,000 | $297.71 | 5.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 20 | $1,040 | $210.60 | 20.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 17 | 17 | $1,020 | $175.95 | 17.3% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 11 | 12 | $960.00 | $149.27 | 15.5% |
| 83735 | Magnesium level | Office | 2023 | 11 | 11 | $825.00 | $72.27 | 8.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 287 | 534 | $238,654 | $56,429 | 23.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 144 | 144 | $65,520 | $22,622 | 34.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 64 | 90 | $28,530 | $7,151 | 25.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 29 | 29 | $16,907 | $5,883 | 34.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 59 | 60 | $12,000 | $4,204 | 35.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 64 | 65 | $5,525 | $2,296 | 41.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 17 | 28 | $14,000 | $1,922 | 13.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $3,520 | $562.05 | 16.0% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 15 | 15 | $2,850 | $552.10 | 19.4% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2022 | 12 | 15 | $4,500 | $514.95 | 11.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 56 | 67 | $10,050 | $513.71 | 5.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 31 | $5,890 | $429.42 | 7.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 11 | 18 | $1,800 | $338.57 | 18.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 30 | 31 | $1,860 | $322.81 | 17.4% |
About Dr. Kenneth Fishberger, MD
Dr. Kenneth Fishberger, MD is a Internal Medicine healthcare provider based in Port Jefferson, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649291451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Fishberger, MD has received a total of $8,334 in payments from pharmaceutical and medical device companies, with $395.13 received in 2024. These payments were reported across 460 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($8,334).
As a Medicare-enrolled provider, Fishberger has provided services to 3,951 Medicare beneficiaries, totaling 5,567 services with total Medicare billing of $412,791. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Port Jefferson, NY
- Active Since 07/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649291451
Products in Payments
- ENTRESTO (Drug) $460.35
- Otezla (Drug) $448.30
- ELIQUIS (Drug) $402.31
- UBRELVY (Drug) $390.67
- Livalo (Drug) $375.36
- JARDIANCE (Drug) $369.99
- XARELTO (Drug) $354.06
- Vascepa (Drug) $321.30
- Edarbi (Drug) $222.21
- TRADJENTA (Drug) $200.73
- BYSTOLIC (Drug) $200.28
- Saxenda (Drug) $196.27
- Repatha (Biological) $191.30
- VRAYLAR (Drug) $186.97
- Aimovig (Biological) $186.53
- CHANTIX (Drug) $156.79
- FARXIGA (Drug) $143.39
- PREVNAR - 13 (Biological) $139.92
- Tresiba (Drug) $135.11
- BYDUREON (Drug) $131.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Port Jefferson
Dr. Norman Bennett, M.d, M.D
Internal Medicine — Payments: $51,558
Sung Whang, Md, MD
Internal Medicine — Payments: $5,126
Phillip Berges
Internal Medicine — Payments: $3,799
Georgia Kulina, M.d, M.D
Internal Medicine — Payments: $3,665
Halyna Chykyda
Internal Medicine — Payments: $3,535
Alexander Gorbatsevich, M.d, M.D
Internal Medicine — Payments: $2,544